RE:RE:RE:It would be a good idea to load todayEoganacht wrote: I don't think it's fair to accuse Theralase of going too slow. They are a small company with limited resources who may be bringing a safe, effective and innovative treatment for cancer to market within the next 2 years with almost no outside help.
As Drs. Lilge and McFarland wrote in their Oct 2018 article:
"TLD1433 progressed from the bench to a clinical trial in 6 years thanks to efforts of a highly productive and motivated multidisciplinary team of chemists, biologists, medical biophysicists, engineers, clinicians, investors, industrial partners, and lawyers. The early identification of the target indication, NMIBC, facilitated the parallel development of compound, medical device, and PDT package via a tumor-centered approach. The creation of a photosensitizer is only one moving part in a much larger machine, and researchers making these compounds must not lose sight of the big picture." I'm just happy I was lucky enough to be able to go along for the ride.
Bunge wrote: DukeDilligence wrote: ...
Yes.
We know TLT.
The faster the better.
Agreed. The pace is appropriate, Even though bladder cancer may be quite prominent, the criteria that make patients eligable for the study is like trying to find a four leaf clover. The fact that they have treated 4 at PMH inside of 4-5 months is fantastic. McGill is now treating and look for London to right there too.
I would hazard a guess that we will see at least one more Canadian site prior to xmas and FDA announced Jan 1. Either way I think it is safe to assume that no news no longer means nothing is happening behind the scenes. Makes for pleasant update, but laser is going to go bannanas without concrete dates to work with....just teasing laser!
Macer